Delivery Order 36F79722D0197-36C26226N0537
Award Date 7/1/26
Potential Completion Date 12/31/30
Potential Value $4.6M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fishers, IN 46037, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 9, issued a BPA call to Telix Pharmaceuticals US Inc. for various radiopharmaceuticals with a ceiling value of $673,700 and an award date of October 1, 2024. The call is issued under the Pharmaceuticals and Drugs FSS Schedule 61-IB. Performance takes place in Fishers, Indiana, with an ultimate completion date of September 30, 2028. The call covers firm fixed-price delivery of radiopharmaceutical products for nuclear medicine...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a $538.6K firm fixed-price delivery order to Telix Pharmaceuticals US Inc. on February 11, 2025, for the procurement of Illuccix, a specialized radiopharmaceutical product used for prostate cancer imaging in nuclear medicine applications. The delivery order, which carries no small business set-aside designation, is scheduled for completion by February 11, 2026, and will be performed in Dublin, Ohio....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $637,000 firm fixed price delivery order to Telix Pharmaceuticals US Inc. for ILLUCCIX GA-68 radiopharmaceuticals over a one-year ordering period. The prime contractor Telix Pharmaceuticals will provide radiopharmaceuticals to VA medical facilities located in Fishers, Indiana under the terms of the contract. ILLUCCIX GA-68 is a type of molecular imaging agent used in positron...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a $99,000 firm fixed-price delivery order to Telix Pharmaceuticals US Inc. for GA68 PSMA Injection on October 25, 2024. This delivery order, with an ultimate completion date of October 24, 2025, does not utilize a small business set-aside designation. The contract represents a call order against Telix Pharmaceuticals' existing federal supply agreements for radiopharmaceutical products, with...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) has awarded Telix Pharmaceuticals US Inc. a Blanket Purchase Agreement (BPA) call order valued at $857.5K for the supply of various radiopharmaceuticals. The contract, effective October 1, 2025, with an ultimate completion date of September 30, 2026, operates as a firm fixed-price delivery order without small business set-aside designation. Telix Pharmaceuticals, headquartered in Fishers, Indiana, will perform the...
- Telix Pharmaceuticals US Inc. has been awarded a $479,500 firm fixed price delivery order against a Blanket Purchase Agreement to provide radiopharmaceutical Illuccix for prostate cancer imaging services. The order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 located in Dublin, Ohio, with a completion date of November 6, 2023. As a manufacturer of radiopharmaceutical goods, Telix Pharmaceuticals supports nuclear medicine...
- Telix Pharmaceuticals US Inc., headquartered in Fishers, Indiana, received a $1.14M firm fixed-price Blanket Purchase Agreement (BPA) call order from Veterans Integrated Service Network 8 (VISN 8), a civilian agency under the Department of Veterans Affairs, with an award date of October 1, 2024, and an ultimate completion date of September 30, 2025. This contract, which carries no set-aside designation, is for the supply of Illuccix, an advanced radiopharmaceutical product used for prostate...
- Telix Pharmaceuticals US Inc. received a $334.8K delivery order award from the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 22 on February 12, 2026, for the supply of Illuccix, a specialized radiopharmaceutical product used for prostate cancer imaging and nuclear medicine diagnostics. The contract is structured as a firm fixed-price delivery order with no small business set-aside designation, with an ultimate completion date of June 30, 2026, and will be performed...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a for-profit manufacturer of goods. The $161,700 contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities through February 2025. This award is part of a larger $17.5 million Blanket Purchase Agreement (BPA) the VA awarded Telix in...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Telix Pharmaceuticals US Inc., a global commercial-stage biopharmaceutical company that manufactures diagnostic and therapeutic radiopharmaceutical products. The $774,700.00 call order is for the supply of various radiopharmaceuticals, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures,...